FENNEC PHARMACEUTICALS INC. Annual Earnings Per Share, Basic in USD/shares from 2010 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Fennec Pharmaceuticals Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2010 to 2023.
  • Fennec Pharmaceuticals Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.21 USD/shares, a 200% decline year-over-year.
  • Fennec Pharmaceuticals Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -0.09 USD/shares, a 88.3% increase year-over-year.
  • Fennec Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2023 was -0.6 USD/shares, a 33.3% increase from 2022.
  • Fennec Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2022 was -0.9 USD/shares, a 34.3% decline from 2021.
  • Fennec Pharmaceuticals Inc. annual Earnings Per Share, Basic for 2021 was -0.67 USD/shares, a 11.8% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$1 +$0.30 +33.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 -$1 $0 -34.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 -$1 +$0.09 +11.8% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 -$1 Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2015 $0 +$0.16 +72.7% Jan 1, 2015 Dec 31, 2015 10-K 2016-03-28
2014 $0 $0 -216% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-28
2013 $0.19 +$0.40 Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
2012 $0 $0 -205% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-31
2011 $0.20 +$0.69 Jan 1, 2011 Dec 31, 2011 10-K 2013-04-01
2010 $0 Jan 1, 2010 Dec 31, 2010 10-K 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.